Don't think it's bad. They have plenty of cash on hand and likely to grow from here. More than likely plan to deploy capital elsewhere or just let it built. They can always announce a new buyback anytime.
- Forums
- ASX - By Stock
- Ann: Final share buy-back notice - Appendix 3F
MYX
mayne pharma group limited
Add to My Watchlist
0.00%
!
$5.22

Don't think it's bad. They have plenty of cash on hand and...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$5.22 |
Change
0.000(0.00%) |
Mkt cap ! $424.1M |
Open | High | Low | Value | Volume |
$5.29 | $5.29 | $5.17 | $18.52K | 3.537K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 2471 | $5.15 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$5.22 | 1 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 2471 | 5.150 |
1 | 4000 | 5.140 |
1 | 150 | 5.120 |
3 | 769 | 5.110 |
3 | 1275 | 5.100 |
Price($) | Vol. | No. |
---|---|---|
5.220 | 1 | 1 |
5.230 | 100 | 1 |
5.240 | 300 | 2 |
5.250 | 150 | 1 |
5.260 | 175 | 1 |
Last trade - 10.25am 18/06/2025 (20 minute delay) ? |
Featured News
MYX (ASX) Chart |
The Watchlist
MEM
MEMPHASYS LIMITED.
Professor John Aitken, Scientific Director
Professor John Aitken
Scientific Director
Previous Video
Next Video
SPONSORED BY The Market Online